Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 30.1.2023 | EN | Official Journal of the European Union | C 35/52 |

---

Judgment of the General Court of 23 November 2022 — Zeta Farmaceutici v EUIPO — Specchiasol (EUPHYTOS)

(Case T-515/21) [(1)](#ntr1-C_2023035EN.01005201-E0001)

(EU trade mark - Invalidity proceedings - EU wordmark EUPHYTOS - Earlier EU figurative mark EuPhidra - Proof of genuine use of the earlier mark - Article 56(2) and Article 43(2) of Regulation (EC) No 40/94 (now Article 64(2) and Article 47(2) of Regulation (EU) 2017/1001) - Relevant periods - Submission of evidence for the first time before the Board of Appeal - Discretion of the Board of Appeal - Article 95(2) of Regulation 2017/1001 - Article 27(4) of Delegated Regulation (EU) 2018/625)

(2023/C 35/61)

Language of the case: Italian

Parties

Applicant: Zeta Farmaceutici SpA (Vicenza, Italy) (represented by: F. Celluprica, F. Fischetti and F. De Bono, lawyers)

Defendant: European Union Intellectual Property Office (represented by: S. Scardocchia, J. Crespo Carrillo and D. Hanf, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: Specchiasol Srl (Bussolengo, Italy)

Re:

By its action under Article 263 TFEU, the applicant seeks annulment and alteration of the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 10 June 2021 (Case R 2094/2019-1).

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Annuls the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 10 June 2021 (Case R 2094/2019-1); |

|  |  |
| --- | --- |
| 2. | Dismisses the action as to the remainder; |

|  |  |
| --- | --- |
| 3. | Orders EUIPO to bear its own costs and to pay those incurred by Zeta Farmaceutici SpA. |

---

---

[Top](#document1)